4D Molecular Therapeutics, Inc.
← Back to FDMT Overview

4D Molecular Therapeutics, Inc. (FDMT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.30

Financial Fundamentals

FDMTQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2018-03-31-19.47
2018-06-30-19.47
2018-09-30-23.55
2018-12-31-23.55
2019-03-31-6.29
2019-06-30-6.29
2019-09-30-9.04
2019-12-31-9.29
2020-03-31-11.38
2020-06-30-9.93
2020-09-30-28.13
2020-12-31-13.46
2021-03-31-17.78
2021-06-30-21.50
2021-09-30-8.22
2021-12-31-5.90
2022-03-31-4.67
2022-06-30-2.05
2022-09-30-2.72
2022-12-31-6.61
2023-03-31-5.18
2023-06-30-5.87
2023-09-30-13.26
2023-12-31-6.10
2024-03-31-11.37
2024-06-30-8.47
2024-09-30-3.42
2024-12-31-1.55
2025-03-31-0.94
2025-06-30-0.95
2025-09-30-2.15
2025-12-315.51
2026-03-31-2.30

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.